Sort
17,828 grants matching “crispr”
Mechanistic Studies of the Type I CRISPR-Cas system
$376,401Scott Bailey · Johns Hopkins University · R01 · FY2021 · GM
Mechanistic Studies of the Type I CRISPR-Cas system
$376,401Scott Bailey · Johns Hopkins University · R01 · FY2023 · GM
Functional characterization of the telomere repeat containing RNA, TERRA, in telomere maintenance
$376,294Rachel L. Flynn · Boston University Medical Campus · R01 · FY2017 · CA
Role of long noncoding RNAs in human ocular angiogenesis
$376,250Shusheng Wang · Tulane University Of Louisiana · R01 · FY2018 · EY
Role of long noncoding RNAs in human ocular angiogenesis
$376,250Shusheng Wang · Tulane University Of Louisiana · R01 · FY2020 · EY
Role of long noncoding RNAs in human ocular angiogenesis
$376,250Shusheng Wang · Tulane University Of Louisiana · R01 · FY2017 · EY
Role of long noncoding RNAs in human ocular angiogenesis
$376,250Shusheng Wang · Tulane University Of Louisiana · R01 · FY2019 · EY
Role of long noncoding RNAs in human ocular angiogenesis
$376,250Shusheng Wang · Tulane University Of Louisiana · R01 · FY2016 · EY
Regulatory Mechanism of Cullin-RING Ubiquitin Ligases
$376,148Xing Liu · Purdue University · R35 · FY2022 · GM
Regulatory Mechanism of Cullin-RING Ubiquitin Ligases
$376,148Xing Liu · Purdue University · R35 · FY2024 · GM
Regulatory Mechanism of Cullin-RING Ubiquitin Ligases
$376,148Xing Liu · Purdue University · R35 · FY2023 · GM
Regulatory Mechanism of Cullin-RING Ubiquitin Ligases
$376,148Xing Liu · Purdue University · R35 · FY2020 · GM
Regulatory Mechanism of Cullin-RING Ubiquitin Ligases
$376,148Xing Liu · Purdue University · R35 · FY2021 · GM
Molecular Genetics Of Early Eye Development
$376,093Stanislav I Tomarev · National Eye Institute · ZIA · FY2015 · EY
Development of a novel therapeutic strategy for treatment of SOD1-linked ALS by CRISPR/Cas9-mediated SOD1 promoter editing
$376,000Han-Xiang Deng · Northwestern University At Chicago · R01 · FY2022 · NS
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
$376,000Adam M Sonabend · Northwestern University At Chicago · R01 · FY2023 · NS
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
$376,000Adam M Sonabend · Northwestern University At Chicago · R01 · FY2022 · NS
Molecular understanding of leukemic bone marrow cytokine-Ras signals and metabolic dependence
$375,891Jeroen Roose · University Of California, San Francisco · R01 · FY2023 · CA
Dysregulation of Wnt signaling in subretinal fibrosis in AMD
$375,876Yusuke Takahashi · Wake Forest University Health Sciences · R01 · FY2022 · EY
Aging and organismal proteostasis-Project 4 RM
$375,856Richard I. Morimoto · Northwestern University · P01 · FY2019 · AG
Mechanism and therapeutic opportunities of targeting the Tudor domain
$375,715Chun-Wei David Chen · Mayo Clinic Rochester · R01 · FY2025 · CA
Mechanisms of Translational Compartmentalization in Eukaryotic Cells
$375,571Christopher V Nicchitta · Duke University · R01 · FY2017 · GM
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma
$375,563Elizabeth P Henske · Brigham And Women'S Hospital · R01 · FY2020 · CA
The Inflammasome as a novel mediator and therapeutic target of GI syndrome
$375,493Richard A Flavell · Yale University · R01 · FY2022 · CA
A Multi-Omics Approach to Discover Metabolic Critical Quality Attributes for Cardiomyocyte Biomanufacturing
$375,430Sean P Palecek · University Of Wisconsin-Madison · R01 · FY2021 · HL